Bill · H.R. 7970· House(119-HR-7970)
STOP Nitazenes Act
- Introduced
- 3/18/2026
- Last activity
- 7/21/2026 — Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.
- Sponsored by
- Robert Latta
- Cosponsors
- - 9 - 1
- Introduced
What this bill would do
This bill, known as the "Strengthening Tools to Outlaw Poisonous Nitazenes Act" or the "STOP Nitazenes Act," seeks to amend the Controlled Substances Act. The primary goal is to permanently schedule 2-benzylbenzimidazole opioids, commonly called nitazenes, as Schedule s controlled substances. It provides a specific definition for these substances, including several specific examples like etonitazene and metonitazene. The Act also ensures that any substances previously under temporary status are moved to permanent Schedule I status. Finally, it establishes a timeline and procedure for the Attorney General to issue rules to implement these changes.
Yes
Does this give the federal government more power?+5
The bill expands federal authority by permanently scheduling specific substances under the Controlled Substances Act.
Does this do more about addiction and overdose deaths?+5
The bill helps combat the opioid crisis by permanently scheduling highly potent nitazene opioids as Schedule I substances.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Permanent Regulation of Nitazenes: By amending the Controlled Substances Act, the bill moves nitazenes into Schedule I, which provides a permanent legal classification for these substances (Section 2).
-
Broad Definition of Controlled Substances: The bill includes a wide range of substances under the definition of 2-benzylbenzimidazole opioids, including various salts, isomers, and specific substances like etonitazene and protonitazene (Section 2(a)).
-
Streamlined Implementation: The Attorney General is empowered to issue interim final rules that become immediately effective to implement the Act (Section 3(a)).
Potential Negative Impacts for People
- No specific negative impacts or burdens are explicitly detailed in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Governance And Ideology
- Increases Federal Power+5
- Healthcare
- Improves Opioid Crisis Response+5
- 7/22/2026
- 1 Cosponsor added.
- 7/21/2026
- Committee Consideration and Mark-up Session Held
- Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.
- 7/20/2026
- Committee Consideration and Mark-up Session Held
- 7/13/2026
- 1 Cosponsor added.
- 6/30/2026
- 1 Cosponsor added.
- 6/25/2026
- Subcommittee Consideration and Mark-up Session Held
- Forwarded by Subcommittee to Full Committee by Voice Vote.
- 5/13/2026
- 1 Cosponsor added.
- 4/27/2026
- 2 Cosponsors added.
- 4/9/2026
- 1 Cosponsor added.
- 3/27/2026
- 2 Cosponsors added.
- 3/26/2026
- 1 Cosponsor added.
- 3/18/2026
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Referred to the Subcommittee on Health.
- Introduced in House
James BairdRepublican · Indiana
Michael BaumgartnerRepublican · Washington
Ken CalvertRepublican · California
Craig GoldmanRepublican · Texas
David JoyceRepublican · Ohio
Tracey MannRepublican · Kansas
Tim MooreRepublican · North Carolina
Addison McDowellRepublican · North Carolina
August PflugerRepublican · Texas
Eugene VindmanDemocrat · Virginia